Arch Therapeutics, Inc.
Company Snapshot: Arch Therapeutics, Inc.
Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.
- Feb 18 2021 Arch Therapeutics Announces Closing of $6.9 Million Private Placement
- Feb 12 2021 Arch Therapeutics Announces $6.9 Million Private Placement
- Jan 5 2021 Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021
- Jan 4 2021 Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.